Immunogenic and Protective Properties of Neisseria meningitidis IgA1 Protease and of Its Truncated Fragments
- Авторы: Zinchenko A.A.1, Kotelnikova O.V.1, Gordeeva E.A.1, Prokopenko Y.A.1, Razgulyaeva O.A.1, Serova O.V.1, Melikhova T.D.1, Nokel E.A.1, Zhigis L.S.1, Zueva V.S.1, Alliluev A.P.2, Rumsh L.D.1
-
Учреждения:
- Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry
- Central Research Institute of Epidemiology of the Federal Service on Customers’ Rights Protection and Human Well-Being Surveillance
- Выпуск: Том 44, № 1 (2018)
- Страницы: 64-72
- Раздел: Article
- URL: https://journals.rcsi.science/1068-1620/article/view/228819
- DOI: https://doi.org/10.1134/S1068162018010193
- ID: 228819
Цитировать
Аннотация
Four recombinant proteins, MA28–P1004LEH6, ME135–H328LEH6, MW329–H622LEH6 and MH835–P1004LEH6, were prepared based on the genomic sequence of IgA1 protease from Neisseria meningitidis serogroup B strain H44/76. The immunogenic and protective properties of these proteins were studied in a mouse model. The predicted T- and B-epitopes located in the N-terminal part of amino acid sequence of this enzyme are very important for the formation of effective protection against meningococci of the three main epidemic serogroups A, B, and C. The small-sized recombinant protein having the sequence ME135–H328LEH6 (molecular weight 23367 Da) appears to be as protective against meningococci of the tested serogroups as the high molecular MA28–P1004LEH6 (molecular weight 109019 Da), the latter being a large-sized analog of full-length IgA1 protease. These proteins can be promising candidates for a polyvalent meningococcal vaccine.
Ключевые слова
Об авторах
A. Zinchenko
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry
Email: zhigis@mail.ibch.ru
Россия, Moscow, 117997
O. Kotelnikova
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry
Email: zhigis@mail.ibch.ru
Россия, Moscow, 117997
E. Gordeeva
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry
Email: zhigis@mail.ibch.ru
Россия, Moscow, 117997
Yu. Prokopenko
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry
Email: zhigis@mail.ibch.ru
Россия, Moscow, 117997
O. Razgulyaeva
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry
Email: zhigis@mail.ibch.ru
Россия, Moscow, 117997
O. Serova
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry
Email: zhigis@mail.ibch.ru
Россия, Moscow, 117997
T. Melikhova
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry
Email: zhigis@mail.ibch.ru
Россия, Moscow, 117997
E. Nokel
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry
Email: zhigis@mail.ibch.ru
Россия, Moscow, 117997
L. Zhigis
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry
Автор, ответственный за переписку.
Email: zhigis@mail.ibch.ru
Россия, Moscow, 117997
V. Zueva
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry
Email: zhigis@mail.ibch.ru
Россия, Moscow, 117997
A. Alliluev
Central Research Institute of Epidemiology of the Federal Service on Customers’ Rights Protection and Human Well-Being Surveillance
Email: zhigis@mail.ibch.ru
Россия, Moscow, 111123
L. Rumsh
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry
Email: zhigis@mail.ibch.ru
Россия, Moscow, 117997
Дополнительные файлы
